相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018
Rajesh Sharma
EPMA JOURNAL (2020)
Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis
Samira Bahrami et al.
CURRENT MOLECULAR PHARMACOLOGY (2020)
CD133: beyond a cancer stem cell biomarker
Amir Barzegar Behrooz et al.
JOURNAL OF DRUG TARGETING (2019)
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
Antonio Jimeno et al.
INVESTIGATIONAL NEW DRUGS (2019)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
Jessica B. Casaletto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Reyes Gonzalez-Exposito et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunotherapeutic Approaches for the Treatment of Colorectal Cancer
E. V. Abakushina et al.
BIOCHEMISTRY-MOSCOW (2019)
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
Davide Ciardiello et al.
CANCER TREATMENT REVIEWS (2019)
CD133 as a regulator of cancer metastasis through the cancer stem cells
Geou-Yarh Liou
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Global trends in colorectal cancer mortality: projections to the year 2035
Marzieh Araghi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
New therapies and insights into the changing landscape of colorectal cancer
Scott Kopetz
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Mostafa Akbarzadeh Khiavi et al.
BIOIMPACTS (2019)
The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy
Siew-Kee Low et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
An enrichment model using regular health examination data for early detection of colorectal cancer
Qiang Shi et al.
CHINESE JOURNAL OF CANCER RESEARCH (2019)
Chicken-Derived Humanized Antibody Targeting a Novel Epitope F2pep of Fibroblast Growth Factor Receptor 2: Potential Cancer Therapeutic Agent
Keng-Chang Tsai et al.
ACS OMEGA (2019)
Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology
Behzad Jafari et al.
SLAS DISCOVERY (2018)
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Frizzled Receptors as Potential Therapeutic Targets in Human Cancers
Chui-Mian Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer
Paul A. Moore et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell
Cong-Min Zhang et al.
PERSONALIZED MEDICINE (2018)
Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers
Aleksandra Borek et al.
PLOS ONE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers
Zhihao Wu et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
New development strategies of immunotherapy agents for colorectal cancer
Josep Tabernero
ANNALS OF ONCOLOGY (2018)
Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
Fang-Rui Liu et al.
BMC CANCER (2018)
The role of CD133 in cancer: a concise review
Paige M. Glumac et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells
Shirin Eyvazi et al.
IMMUNOLOGY LETTERS (2017)
Targeted cancer therapy through antibody fragments-decorated nanomedicines
Abbas Alibakhshi et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies
Elmira Safaie Qamsari et al.
JOURNAL OF IMMUNOTOXICOLOGY (2017)
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
Sarah M. Cheal et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Potential mechanisms of CD133 in cancer stem cells
Jae-Woo Jang et al.
LIFE SCIENCES (2017)
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
Pravin U. Dugel et al.
OPHTHALMOLOGY (2017)
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
Alex Francoso et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
Wei Xia Ang et al.
ONCOTARGET (2017)
Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target
Seyed Khalil Rashidi et al.
IRANIAN JOURNAL OF BIOTECHNOLOGY (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
Katerina T. Xenaki et al.
FRONTIERS IN IMMUNOLOGY (2017)
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
Sarah M. Cheal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+Colorectal Cancer Cells
J. U. Schmohl et al.
TARGETED ONCOLOGY (2016)
Periplasmic expression, purification, and characterization of an anti-epidermal growth factor receptor antibody fragment in Escherichia coli
Won-Jae Chi et al.
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING (2016)
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) X c-MET Antibodies and Antibody-Drug Conjugates
Carolin Sellmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
Joerg U. Schmohl et al.
MOLECULAR THERAPY (2016)
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)
Bahman Akbari et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Role of targeted therapy in metastatic colorectal cancer
Yoshihito Ohhara et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer
Sara Zalba et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
Lei Zhao et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
Jaime Tome-Amat et al.
SPRINGERPLUS (2015)
A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment
Zahra Farajpour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Tests and investigations for colorectal cancer screening
Magdalen R. R. Carroll et al.
CLINICAL BIOCHEMISTRY (2014)
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma
Achim Rothe et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma
Nate N. Waldron et al.
TARGETED ONCOLOGY (2014)
Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives
Caterina Fanali et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
J. P. Tiernan et al.
BRITISH JOURNAL OF CANCER (2013)
Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
Daniel A. Vallera et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Targeted therapy in metastatic colorectal cancer - An example of personalised medicine in action
V. Heinemann et al.
CANCER TREATMENT REVIEWS (2013)
Progress in the identification of plasma biomarkers of colorectal cancer
Caroline Coghlin et al.
PROTEOMICS (2013)
Targeted therapies in colorectal cancer—an integrative view by PPPM
Suzanne Hagan et al.
EPMA Journal (2013)
Production and characterization of scFvA33T1, an immunoRNase targeting colon cancer cells
Jaime Tome-Amat et al.
FEBS JOURNAL (2012)
Activated leukocyte cell adhesion molecule (CD166)-Its prognostic power for colorectal cancer patients
Michael Tachezy et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool
Marleen van Oosten et al.
TRANSLATIONAL ONCOLOGY (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
T. Osada et al.
BRITISH JOURNAL OF CANCER (2010)
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
Merete Thune Wiiger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Monoclonal Antibodies in the Treatment of Metastatic Colorectal Cancer: A Review
Jolien Tol et al.
CLINICAL THERAPEUTICS (2010)
Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins
Shiran Shapira et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells
Ines Herrmann et al.
PLOS ONE (2010)
Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA
Ralf Lutterbuese et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2
Hua-Quan Miao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments:: a clinical phase I/II study
JL Casey et al.
BRITISH JOURNAL OF CANCER (2002)
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments
PJ Yazaki et al.
BIOCONJUGATE CHEMISTRY (2001)
分享论文
